The Secret Weapon in Liquid Finishing Technology is Nitrotherm

 

Manufacturing a Stronger Standard kicked off a new series of podcasts, titled “What’s New in Finishing Technology,” with a discussion on Nitrotherm®️. This liquid spray-painting method utilizes nitrogen instead of normal compressed air. Derek DeGeest, President of DeGeest Corporation & Lesta USA, and Bill Robinson, President of Coating Delivery Technology, spoke about the benefits of Nitrothem, which reduces solvent consumption reduction of VOC emissions by up to 50% and provides manufacturing cost savings.

Call DeGeest the Indiana Jones of the finishing world. When DeGeest hits the European scene, he’s on a treasure hunt to find and bring back technology to improve America’s manufacturing processes.

And it was on one of those European trips where he first discovered Nitrotherm®️. DeGeest noted finishing shops in Europe do things a little bit differently.

“We were traveling over in Europe looking at our Lesta robots, learning how to use them, visiting customers and seeing how they were using robots,” he said. During conversations with these other shops, Nitrotherm®️ kept coming up. “Once we found out what it did and what it was, we knew we had to bring it to our operation.”

Robinson mentioned his surprise when he got a call from DeGeest to order 4 Nitrotherm®️ systems, sight unseen. He thought maybe DeGeest was biting off more than they could handle with all of their new robotic technology and ancillary solutions, but, to his delight and surprise, DeGeest’s gambit is paying off.

 

“It’s just been a great alliance, because they have the understanding of the robots and they have the Nitrotherm’s®️ there, and now they have them in their Test Lab. It’s a great opportunity for people to see what it does with their application in a real environment,” Robinson said.

 

DeGeest and Robinson agreed that the efficiencies brought on through the use of the Nitrotherm®️ spraying system are significant; DeGeest said that when his company started using Nitrotherm®️, their paint consumption went down 30%, filter life doubled, and there was a reduction in Faraday Effect, flash times and cure times.

 

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More